Cargando…

Non-invasive in vivo determination of viable islet graft volume by (111)In-exendin-3

Pancreatic islet transplantation is a promising therapy for patients with type 1 diabetes. However, the duration of long-term graft survival is limited due to inflammatory as well as non-inflammatory processes and routine clinical tests are not suitable to monitor islet survival. (111)In-exendin-SPE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eter, Wael A., Van der Kroon, Inge, Andralojc, Karolina, Buitinga, Mijke, Willekens, Stefanie M. A., Frielink, Cathelijne, Bos, Desiree, Joosten, Lieke, Boerman, Otto C., Brom, Maarten, Gotthardt, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543140/ https://www.ncbi.nlm.nih.gov/pubmed/28775287 http://dx.doi.org/10.1038/s41598-017-07815-3

Ejemplares similares

Graft revascularization is essential for non-invasive monitoring of transplanted islets with radiolabeled exendin
por: Eter, Wael A., et al.
Publicado: (2015)

(111)In-exendin Uptake in the Pancreas Correlates With the β-Cell Mass and Not With the α-Cell Mass
por: Brom, Maarten, et al.
Publicado: (2015)

Whole organ and islet of Langerhans dosimetry for calculation of absorbed doses resulting from imaging with radiolabeled exendin
por: van der Kroon, Inge, et al.
Publicado: (2017)

Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW
por: Boss, Marti, et al.
Publicado: (2020)

Exendin‐4 analogs in insulinoma theranostics
por: Jansen, Tom.J.P., et al.
Publicado: (2019)

New Radiolabeled Exendin Analogues Show Reduced Renal Retention
por: Joosten, Lieke, et al.
Publicado: (2023)

Characterization of (111)In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors
por: Willekens, Stefanie M. A., et al.
Publicado: (2018)

The effect of purification of Ga-68-labeled exendin on in vivo distribution
por: Brom, Maarten, et al.
Publicado: (2016)

Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin
por: Willekens, Stefanie M. A., et al.
Publicado: (2016)

SPECT-OPT multimodal imaging enables accurate evaluation of radiotracers for β-cell mass assessments
por: Eter, Wael A., et al.
Publicado: (2016)

Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
por: Boss, Marti, et al.
Publicado: (2020)

(68)Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET
por: Brom, Maarten, et al.
Publicado: (2010)

Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39)
por: Collado Camps, Estel, et al.
Publicado: (2022)

Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging
por: Joosten, Lieke, et al.
Publicado: (2017)

PET-Based Human Dosimetry of (68)Ga-NODAGA-Exendin-4, a Tracer for β-Cell Imaging
por: Boss, Marti, et al.
Publicado: (2020)

Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer
por: Brom, Maarten, et al.
Publicado: (2012)

(68)Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism
por: Boss, Marti, et al.
Publicado: (2022)

(18)F-Labelled exendin to image GLP-1 receptor-expressing tissues: from niche to blockbuster?
por: Boerman, Otto C., et al.
Publicado: (2011)

Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan
por: Joosten, Lieke, et al.
Publicado: (2017)

Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis
por: Andralojc, K., et al.
Publicado: (2012)

Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis
por: Dorst, Daphne N, et al.
Publicado: (2020)

Pancreatic islet macroencapsulation using microwell porous membranes
por: Skrzypek, Katarzyna, et al.
Publicado: (2017)

Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors
por: Lütje, Susanne, et al.
Publicado: (2019)

Importance of beta cell mass for glycaemic control in people with type 1 diabetes
por: Jansen, Theodorus J. P., et al.
Publicado: (2022)

Microwell Scaffolds for the Extrahepatic Transplantation of Islets of Langerhans
por: Buitinga, Mijke, et al.
Publicado: (2013)

A 3D-printed anatomical pancreas and kidney phantom for optimizing SPECT/CT reconstruction settings in beta cell imaging using (111)In-exendin
por: Woliner-van der Weg, Wietske, et al.
Publicado: (2016)

Photodynamic Therapy Targeting Macrophages Using IRDye700DX-Liposomes Decreases Experimental Arthritis Development
por: Dorst, Daphne N., et al.
Publicado: (2021)

Quantification of β-Cell Mass in Intramuscular Islet Grafts Using Radiolabeled Exendin-4
por: Espes, Daniel, et al.
Publicado: (2016)

Suppression of ROS Production by Exendin-4 in PSC Attenuates the High Glucose-Induced Islet Fibrosis
por: Kim, Ji-Won, et al.
Publicado: (2016)

CPPs to the Test: Effects on Binding, Uptake and Biodistribution of a Tumor Targeting Nanobody
por: Collado Camps, Estel, et al.
Publicado: (2021)

Comparative biodistribution of 12 (111)In-labelled gastrin/CCK2 receptor-targeting peptides
por: Laverman, Peter, et al.
Publicado: (2011)

Investigation of the preservation effect of canagliflozin on pancreatic beta cell mass using SPECT/CT imaging with (111)In-labeled exendin-4
por: Hamamatsu, Keita, et al.
Publicado: (2019)

Effect of miR-19b on the protective effect of Exendin-4 on islet cells in non-obese diabetic mice
por: He, Jinshui, et al.
Publicado: (2019)

Diannexin Protects against Renal Ischemia Reperfusion Injury and Targets Phosphatidylserines in Ischemic Tissue
por: Wever, Kimberley E., et al.
Publicado: (2011)

Brain Imaging of the GLP-1 Receptor in Obesity Using (68)Ga-NODAGA-Exendin-4 PET
por: Deden, Laura N., et al.
Publicado: (2021)

Detection and quantification of beta cells by PET imaging: why clinical implementation has never been closer
por: Gotthardt, Martin, et al.
Publicado: (2018)

Exendin-4 for Parkinson's disease
por: Esparza-Salazar, Felipe de Jesús, et al.
Publicado: (2021)

Preservation effect of imeglimin on pancreatic β-cell mass: Noninvasive evaluation using (111)In-exendin-4 SPECT/CT imaging and the perspective of mitochondrial involvements
por: Fauzi, Muhammad, et al.
Publicado: (2022)

Exendin-4 Suppresses Src Activation and Reactive Oxygen Species Production in Diabetic Goto-Kakizaki Rat Islets in an Epac-Dependent Manner
por: Mukai, Eri, et al.
Publicado: (2011)

The Effects of Exendin-4 Treatment on Graft Failure: An Animal Study Using a Novel Re-Vascularized Minimal Human Islet Transplant Model
por: Sahraoui, Afaf, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_72gpe19rhp1e0qki4ign2ejnkd